Elecsys Ca 125 Ii
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K972162, from Boehringer Mannheim Corp. (Indianapolis, IN). Product code LTK, class 2.
As of Nov 19, 2026, K972162 is an FDA 510(k) held by Boehringer Mannheim Corp., substantially equivalent on Mar 18, 1998 after 282 days, with no recalls tied to it in FDA's recall database.
- Review time: 282 days
- Recalls: 0
- Cited as a predicate by: 3 devices
- Vitros Immunodiagnostic Products Ca 125 Ii Calibrators, Vitros Immunodiagnostic Products Ca 125 Ii Reagent PackK983875 · Ortho-Clinical Diagnostics, Inc. · May 14, 1999
- Elecsys Ca 125II On The Elecsys 1010K980240 · Boehringer Mannheim Corp. · Mar 25, 1998
- Elecsys CA-125 II assayK143534 · Roche Professional Diagnostics · Aug 6, 2015
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 9, 1997
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files